The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients
Open Access
- 29 December 2015
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 1-10
Abstract
Maintaining optimal fluid balance is essential in haemodialysis (HD) patients but clinical evaluation remains problematic. Other technologies such as bioimpedance are emerging as valuable adjuncts. This study was undertaken to explore the potential utility of the natriuretic peptides – atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) in the assessment of fluid status and cardiovascular risk in this setting. This was a cross-sectional study carried out in an unselected cohort of 170 prevalent HD patients. Volume status was assessed by clinical parameters – the presence or absence of peripheral oedema, raised jugular venous pressure and basal lung crepitations; by extracellular fluid volume (ECFV) status determined by whole body bioimpedance; and by serum levels of BNP and ANP (pre- and post –dialysis). The relationships of ANP and BNP levels to clinical and bioimpedance parameters of volume status was determined. Patients were followed up for 5 years to assess the relationship of natriuretic peptide levels to mortality. Bioimpedance estimates of ECFV expansion (>105 % of ideal ECFV) was present in 52 % of patients pre-dialysis. A significant proportion (21 %) of pre-dialysis patients had a depleted ECFV (3 cm was the most reliable clinical sign of ECFV expansion inferred from bioimpedance measurements and natriuretic peptide levels. The vast majority of patients with this sign also had lung crepitations or peripheral oedema or both. BNP was a stronger predictor of ECFV expansion than either pre- or post-dialysis ANP. BNP was also a stronger predictor of five-year survival. Serum levels of BNP have a strong relationship to both volume status and survival in HD patients. We found no clear role for measurement of ANP, though changes in blood levels may be a sensitive indicator of acute changes in volume status. Whether monitoring levels of these peptides has a role in the management of volume status and cardiovascular risk requires further study.Keywords
This publication has 41 references indexed in Scilit:
- Bioimpedance-Guided Fluid Management in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2013
- Inhibition of the P2X7 Receptor Reduces Cystogenesis in PKDJournal of the American Society of Nephrology, 2011
- Intradialytic Hypotension and Vascular Access ThrombosisJournal of the American Society of Nephrology, 2011
- N-terminal proBNP—Marker of Cardiac Dysfunction, Fluid Overload, or Malnutrition in Hemodialysis Patients?Clinical Journal of the American Society of Nephrology, 2010
- Haemodialysis-Induced Myocardial Stunning in Chronic Kidney Disease – A New Aspect of Cardiovascular DiseaseBlood Purification, 2010
- NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patientsNephrology Dialysis Transplantation, 2009
- Relationships of N-Terminal Pro–B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007
- Degradation of brain natriuretic peptide by neutral endopeptidase: Species specific sites of proteolysis determined by mass spectrometryBiochemical and Biophysical Research Communications, 1991
- Beeinflussung von atrialem natriuretischen Peptid (ANP) und zyklischem GMP durch Hämofiltration und HämodialyseJournal of Molecular Medicine, 1988
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987